Morgan Stanley initiates IMAX at 'overweight' on premium entertainment demand
IMAX•Morgan Stanley initiated coverage of IMAX with an 'overweight' rating and a $63 price target, implying 14.2% upside to its last close.
1. Growth outlook
Morgan Stanley described IMAX's premium out-of-home entertainment business model as largely AI-proof and expected sustainable long-term box office and network growth. It estimated North American box office at $10.7 billion in 2026 and $10.9 billion in 2027; the average rating from 14 analysts was 'buy,' with a median price target of $58.
